NTRK2 and Alzheimer disease: Consistently, activation of TrkB is involved in AD actions and also lithium and ketamine, which likewise amplified HTC-Waves, enforce TrkB signaling (Castrén and Rantamäki, 2010; Autry et al., 2011).